Surgery for intracerebral haemorrhage – Authors' reply
- 1 August 2019
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 394 (10199), e22-e23
- https://doi.org/10.1016/s0140-6736(19)31416-3
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureNeurosurgery, 2019
- Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialThe Lancet, 2019
- Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialThe Lancet Neurology, 2016